Desmoid Tumor Completed Phase 3 Trials for Sorafenib (DB00398)

Also known as: Desmoid-Type Fibromatosis / Desmoid Type-fibromatosis / Aggressive Fibromatosis / Desmoid tumour / Fibromatosis, Aggressive / Desmoid Tumors / Fibromatosis Desmoid / Desmoid Fibromatosis / Aggressive fibromatosis (disorder) / Aggressive fibromatosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0028471 (Desmoid Tumor)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02066181Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive FibromatosisTreatment